Quantum BioPharma Statistics
Total Valuation
CSE:QNTM has a market cap or net worth of CAD 62.42 million. The enterprise value is 57.45 million.
Market Cap | 62.42M |
Enterprise Value | 57.45M |
Important Dates
The last earnings date was Monday, May 12, 2025.
Earnings Date | May 12, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CSE:QNTM has 3.05 million shares outstanding. The number of shares has increased by 162.08% in one year.
Current Share Class | 3.04M |
Shares Outstanding | 3.05M |
Shares Change (YoY) | +162.08% |
Shares Change (QoQ) | +24.88% |
Owned by Insiders (%) | 11.67% |
Owned by Institutions (%) | 2.67% |
Float | 2.69M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 9.59 |
P/TBV Ratio | 48.12 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -1.91 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.96, with a Debt / Equity ratio of 0.28.
Current Ratio | 0.96 |
Quick Ratio | 0.67 |
Debt / Equity | 0.28 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -46.54 |
Financial Efficiency
Return on equity (ROE) is -268.81% and return on invested capital (ROIC) is -120.32%.
Return on Equity (ROE) | -268.81% |
Return on Assets (ROA) | -71.24% |
Return on Invested Capital (ROIC) | -120.32% |
Return on Capital Employed (ROCE) | -381.45% |
Revenue Per Employee | n/a |
Profits Per Employee | -1.77M |
Employee Count | 17 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -9.89% in the last 52 weeks. The beta is 1.47, so CSE:QNTM's price volatility has been higher than the market average.
Beta (5Y) | 1.47 |
52-Week Price Change | -9.89% |
50-Day Moving Average | 12.58 |
200-Day Moving Average | 8.33 |
Relative Strength Index (RSI) | 68.68 |
Average Volume (20 Days) | 7,539 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -24.83M |
Pretax Income | -30.99M |
Net Income | -30.01M |
EBITDA | -24.11M |
EBIT | -24.83M |
Earnings Per Share (EPS) | -18.72 |
Balance Sheet
The company has 5.09 million in cash and 1.84 million in debt, giving a net cash position of 3.25 million or 1.07 per share.
Cash & Cash Equivalents | 5.09M |
Total Debt | 1.84M |
Net Cash | 3.25M |
Net Cash Per Share | 1.07 |
Equity (Book Value) | 6.51M |
Book Value Per Share | 3.04 |
Working Capital | -593,025 |
Cash Flow
Operating Cash Flow | -13.17M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CSE:QNTM does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -162.08% |
Shareholder Yield | n/a |
Earnings Yield | -48.07% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on August 15, 2024. It was a reverse split with a ratio of 0.0153846154.
Last Split Date | Aug 15, 2024 |
Split Type | Reverse |
Split Ratio | 0.0153846154 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |